000 | 01868 a2200481 4500 | ||
---|---|---|---|
005 | 20250516055905.0 | ||
264 | 0 | _c20120201 | |
008 | 201202s 0 0 eng d | ||
022 | _a1989-2284 | ||
024 | 7 |
_a10.3265/Nefrologia.pre2011.Jun.10968 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aViñolo López, M C | |
245 | 0 | 0 |
_aClinical case: Peritoneal dialysis patient with cloudy peritoneal fluid following administration of calcium antagonists. _h[electronic resource] |
260 |
_bNefrologia : publicacion oficial de la Sociedad Espanola Nefrologia _c2011 |
||
300 |
_a624 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Letter | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntihypertensive Agents _xadverse effects |
650 | 0 | 4 |
_aAscitic Fluid _xchemistry |
650 | 0 | 4 |
_aCalcium Channel Blockers _xadverse effects |
650 | 0 | 4 |
_aCardiovascular Agents _xtherapeutic use |
650 | 0 | 4 |
_aChylous Ascites _xchemically induced |
650 | 0 | 4 | _aDiagnosis, Differential |
650 | 0 | 4 |
_aDihydropyridines _xadverse effects |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlomerulonephritis, Membranoproliferative _xtherapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney Failure, Chronic _xetiology |
650 | 0 | 4 |
_aNifedipine _xadverse effects |
650 | 0 | 4 | _aNitrobenzenes |
650 | 0 | 4 | _aPeritoneal Dialysis, Continuous Ambulatory |
650 | 0 | 4 |
_aPeritonitis _xdiagnosis |
650 | 0 | 4 | _aPiperazines |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aTriglycerides _xanalysis |
700 | 1 | _aGutiérrez Rivas, P C | |
700 | 1 | _aLiébana Cañada, A | |
700 | 1 | _aGil Cunquero, J M | |
700 | 1 | _aMerino García, E | |
773 | 0 |
_tNefrologia : publicacion oficial de la Sociedad Espanola Nefrologia _gvol. 31 _gno. 5 _gp. 624 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3265/Nefrologia.pre2011.Jun.10968 _zAvailable from publisher's website |
999 |
_c21196430 _d21196430 |